CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 120 enrolled
Drug / intervention
Decapeptyl Daily +1 moredrug
Likely dose
Decapeptyl Daily 0.2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01607203
NCT01607203Phase 4Completed
CompareCT.gov

Randomised Controlled Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

AZ Jan Palfijn Gent·interventional·Posted May 30, 2012·Updated Feb 19, 2015

In Brief

A Phase 4 clinical trial evaluating Decapeptyl Daily and pregnyl for Infertility. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The purpose of this study is to see whether patients triggered with only human Chorion Gonadotropin (hCG) have higher number of Metaphase II oocytes (MII) and implantation rate than patients triggered with hCG combined with Gonadotropin Releasing Hormone (GnRH) agonist.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesBelgium
CollaboratorsOnze Lieve Vrouw Hospital

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 30, 2012
Enrollment StartNov 1, 2011
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.1 years ago

Interventions

Decapeptyl Dailydrug

Decapeptyl 0.2 mg SC once 1day

pregnyldrug

5000 IU SC